Sponsored Links
| Poniard Pharmaceuticals Announces Updated Positive Clinical Data From Phase 2 Trial Of Picoplatin In Colorectal Cancer |
 |
 |
 |
| Medical News - Colorectal Cancer | |||
|
Poniard Pharmaceuticals, Inc. (Nasdaq: PARD) announced updated clinical data from its randomized, controlled Phase 2 trial of picoplatin in patients with metastatic colorectal cancer (CRC)... Read more: Colorectal Cancer News From Medical News Today
|